Vayarin is marketed as a “medical food” for the treatment of ADHD. Vayarin contains Phosphatidylserine 75 mg, Eicosapentaenoic acid (EPA) 21.5 mg, and Docosahexaenoic acid (DHA) 8.5 mg. These ingredients are omega3 fatty acids. The recommended dose is 4 pills daily.
The company sponsored a 15-week, double blind, placebo controlled trial ... Read More
Category: Doctor’s Blog
04
Nov2015
Insurance companies and "health care coordinators" are increasingly insinuating themselves into the care of patients. While we are all accustom to generic substitutions as a cost saving measure, you may not be aware that a pharmacist of CareFirst is "working with primary care physicians" to review cost effective medication treatments ... Read More
November 4, 2015David W. Goodman, MD
13
Oct2015
On September 30, 2015, The New York Times ran an article in the Tuesday Science section on ADHD in older adults. I was interviewed for the article and discussed a former patient age 73 who was first diagnosis with ADHD by me and successfully treated. The article is an introduction ... Read More
October 13, 2015David W. Goodman, MD
20
Apr2015
In my periodic entries of insurance companies' denial of ADHD medication dosing, I offer you this recent example.
A female in her late 20s treated for ADHD with a combination of Adderall XR and Strattera. Strattera adds a benefit for her executive function not optimized with Adderall XR. I carefully dosed ... Read More
April 20, 2015David W. Goodman, MD
24
Mar2015
With marijuana legislation slowly and effectively moving the dial from medical marijuana to legal recreational use, many baby boomers who smoked pot in their younger years are shrugging their shoulders and saying "Why not?". The presumption is "I smoked it and turned out ok. What's the big deal to legalization?" ... Read More
March 24, 2015David W. Goodman, MD
18
Mar2015
Help support our mission.
Children and Adults with ADHD Association is the only U.S. national organization that addresses the needs of people and families wrestling with ADHD. They serve as a legislative advocate on a regional and national level, provider and supporter of local chapter support groups, distributor of peer-reviewed educational ... Read More
March 18, 2015David W. Goodman, MD
02
Mar2015
Chris Davis set a club record last year with 53 home runs. Yet, his presence in the media now has more to do with his ADHD and suspension for the use of Adderall. This has been a set of unfortunate circumstances since Mr. Davis has ADHD which was diagnosed years ... Read More
March 2, 2015David W. Goodman, MD
04
Feb2015
You might think you're exercising good judgment by enhancing your health and wellbeing by taking herbs and supplements. While the scientific research with replicated studies is limited, the nutraceutical companies have spent billions promoting their use. Yet now, the real problem is uncovered. The New York Times recently published a ... Read More
February 4, 2015David W. Goodman, MD
04
Jan2015
Almost everyday insurance companies request pre-authorization for stimulant medication for my patients. While many of these requests are approved, many others are not. One obstacle to approval is stimulant dosing. Insurance companies routinely deny coverage for any stimulant dose that exceeds FDA drug label maximum dose. You might believe this ... Read More
January 4, 2015David W. Goodman, MD
08
Dec2014
Over the years, it has been challenging for psychiatrists to manage the risks of psychiatric medications in patients who considered childbearing, become pregnant, and chose to breastfeed. And while there is some information on many psychiatric medications, there remains little in regards to stimulant medications. Unfortunately, there is no registry ... Read More
December 8, 2014David W. Goodman, MD